EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Yin-Yang balance of SIRT1 and SIRT2 in cancer metabolic remodeling

Fei Yi, Li Shen, Xindi Yang, Zhuo Wang, Xue Li, Zishi Shen, Wenting Liu, Qi Miao, Shuang Jiang, Eryan Kong, Xiaoyu Song, Tingting Zhou und 2 weitere

International Journal of Biological Sciences · 11.02.2026 · 22 (5) · 2702-2719

DOI: 10.7150/ijbs.127696 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, erschienen am 11.02.2026. Verfasst von Fei Yi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Institute, China Medical University, Shenyang, Liaoning 110122, China. Hauptthemen laut MEDLINE: Neoplasms, Sirtuin 2, Sirtuin 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sirtuin 1 (SIRT1) and Sirtuin 2 (SIRT2) are NAD⁺-dependent deacetylases that regulate cancer metabolic stress, exerting their effects primarily through post-translational modification of metabolic enzymes and transcription factors. They modulate glucose, lipid, and mitochondrial metabolism, as well as immune metabolism responses within the tumor microenvironment. Depending on cellular context, they can promote or suppress tumor growth by directing energy production, redox balance, and metabolic adaptation. These context-dependent and often opposing activities constitute a Yin-Yang mode of regulation in cancer metabolism, reflecting a dynamic balance between metabolic activation and constraint. Autophagy has emerged as a critical metabolic integration node regulated by both SIRT1 and SIRT2, linking nutrient sensing, mitochondrial quality control, and stress adaptation. This review summarizes recent advances in understanding how SIRT1 and SIRT2 coordinate tumor metabolism and discusses therapeutic strategies that target their regulatory balance to reprogram cancer metabolism. SIRT2 also functions as a metabolic checkpoint that restrains CD8⁺ T cell effector metabolism, providing a rationale for combining SIRT2 inhibition with immune checkpoint blockade in metabolically stressed tumor microenvironments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSirtuin 2Sirtuin 1HumansAnimalsMetabolic ReprogrammingTumor Microenvironment

Stichwörter der Autor:innen

SIRT1 and SIRT2glucose metabolismlipid metabolismmitochondrial metabolismtumor immune microenvironment

Substanzen

Sirtuin 2Sirtuin 1

Autor:innen und Institutionen

  • Health Sciences Institute, China Medical University, Shenyang, Liaoning 110122, China.
  • Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
  • Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, Henan 453003, China.
  • Clinical Translational Research Center, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110002, China.

Zitieren

APA

Yi, F., Shen, L., Yang, X., Wang, Z., Li, X., Shen, Z., Liu, W., Miao, Q., Jiang, S., Kong, E., Song, X., Zhou, T., Bai, N., & Cao, L. (2026). The Yin-Yang balance of SIRT1 and SIRT2 in cancer metabolic remodeling. International Journal of Biological Sciences, 22(5), 2702-2719. https://doi.org/10.7150/ijbs.127696

Vancouver

Yi F, Shen L, Yang X, Wang Z, Li X, Shen Z, et al. The Yin-Yang balance of SIRT1 and SIRT2 in cancer metabolic remodeling. International Journal of Biological Sciences. 2026;22(5):2702-2719. doi:10.7150/ijbs.127696

BibTeX
@article{Yi2026,
  author = {Yi, Fei and Shen, Li and Yang, Xindi and Wang, Zhuo and Li, Xue and Shen, Zishi and Liu, Wenting and Miao, Qi and Jiang, Shuang and Kong, Eryan and Song, Xiaoyu and Zhou, Tingting and Bai, Ning and Cao, Liu},
  title = {The Yin-Yang balance of SIRT1 and SIRT2 in cancer metabolic remodeling},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {2702--2719},
  doi = {10.7150/ijbs.127696}
}
Kostenlos starten →